The evolution of entecavir resistance mutation spectrum in patients with chronic hepatitis B virus infection from 2019 to 2024 and its clinical implications
Medical Journal of Chinese People′s Liberation ArmyVol. 51, Issue 2, Pages: 171-177(2026)
Clinical Research|更新时间:2026-03-19
分享给微信好友或者朋友圈
导出参考文献
The evolution of entecavir resistance mutation spectrum in patients with chronic hepatitis B virus infection from 2019 to 2024 and its clinical implications
“Experts from the Fifth Medical Center of the General Hospital of the People's Liberation Army analyzed the characteristics of ETV resistance mutations in patients with chronic HBV infection from 2019 to 2024, revealed the patterns of drug resistance transformation, and provided a basis for rational antiviral treatment in clinical practice.”
作者机构:
1.北京大学三〇二临床医学院,北京 100039
2.解放军总医院感染病医学部,北京 100039
3.解放军总医院肝病医学部,北京 100039
作者简介:
Ji Dong, E-mail: jidg302@126.com
Liu Yan, E-mail: liuyan5360@163.com
基金信息:
the National Natural Science Foundation of China(82470632);the National Key Research and Development Program of China(2023YFC2306800)
Li Xu-Yang,Si Lan-Lan,Li Le,et al.The evolution of entecavir resistance mutation spectrum in patients with chronic hepatitis B virus infection from 2019 to 2024 and its clinical implications[J].Medical Journal of Chinese People′s Liberation Army,2026,51(02):171-177.
Li Xu-Yang,Si Lan-Lan,Li Le,et al.The evolution of entecavir resistance mutation spectrum in patients with chronic hepatitis B virus infection from 2019 to 2024 and its clinical implications[J].Medical Journal of Chinese People′s Liberation Army,2026,51(02):171-177. DOI: 10.11855/j.issn.0577-7402.1561.2025.1219.
The evolution of entecavir resistance mutation spectrum in patients with chronic hepatitis B virus infection from 2019 to 2024 and its clinical implications
Genotypic analysis of entecavir-resistant mutation of hepatitis B virus (HBV) in patients with chronic HBV infection
Characteristics of changes in HBsAg, HBV DNA and ALT after cessation of nucleos(t)ide analogue therapy in patients with HBeAg-negative chronic hepatitis B
Establishment and evaluation of a predictive model for spontaneous peritonitis in HBV-related primary liver cancer
Impact of non-alcoholic fatty liver disease on overall survival in hepatitis B virus-related hepatocellular carcinoma
Related Author
Si Lan-Lan
Li Le
Chen Xue-Yuan
Yao Zeng-Tao
Liu Yan
刘妍
李庆虹
李乐
Related Institution
Senior Department of Infectious Diseases, Chinese PLA General Hospital
军事医学科学院
解放军302医院全军传染病研究所病毒性肝炎研究室
Department of Geriatrics, the Fifth Medical Center of Chinese PLA General Hospital
Department of Infectious Disease Medicine/National Clinical Research Center of Infectious Diseases